No results were found for the filter!
eGFP/Firefly Luciferase JeKo-1 Cell Line
Item number: BPS-82147
The eGFP/Firefly Luciferase JeKo-1 Cell Line is a JeKo-1 cell line expressing firefly luciferase and enhanced GFP (eGFP) driven by an EF1a promoter, generated by transduction with Firefly Luciferase-eGFP lentivirus (BPS Bioscience #78741), which is a SIN0 self-inactivating lentivirus).
| Keywords: | Luciferase, Luciferin 4-monooxygenase, |
| Application: | In vitro/in vivo bioluminescence/fluorescence imaging, CAR-T/NK co-culture killing assay target cells |
4,420.00€
*
eGFP/Firefly Luciferase THP-1 Cell Line
Item number: BPS-82148
eGFP/Firefly Luciferase THP-1 Cell Line is a THP-1 cell line expressing firefly luciferase and enhanced GFP (eGFP) driven by an EF1a promoter. The cells were generated by transduction with Firefly Luciferase-eGFP lentivirus (BPS Bioscience #78741), which is a SIN (self-inactivating) lentivirus.
| Keywords: | Luciferase, Luciferin 4-monooxygenase, |
| Application: | In vitro/in vivo bioluminescence/fluorescence imaging, CAR-T/NK co-culture killing assay target cells |
2,985.00€
*
B2M Knockout iPS Cell Line
Item number: BPS-82161
The B2M Knockout iPS Cell Line is an iPS cell line that has been edited using CRISPR/Cas9 technology to delete B2M (Beta-2-Microglobulin) gene expression. The B2M-targeting CRISPR/Cas9 editing agents were delivered via transduction with B2M (Human) CRISPR/Cas9 Lentivirus (Non-Integrating) (BPS Bioscience #78341).
| Keywords: | CDABP0092, |
| Application: | B2M knockout role/impact in iPS cell biology/differentiation/cell therapy assessment |
| Species reactivity: | human |
9,302.00€
*
CD19 Knockout Raji Cell Line
Item number: BPS-82166
CD19 Knockout Raji Cell Line is a Raji cell line where CD19 (Cluster of Differentiation 19, B-lymphocyte surface antigen B4, or CVID3) has been genetically removed from Raji cells using CRISPR/Cas9 genome editing.
| Keywords: | CD19, B-lymphocyte antigen CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte surface antigen... |
| Application: | CAR-T / NK co-culture killing assay control |
| Species reactivity: | human |
5,298.00€
*
Firefly Luciferase CD19 Knockout Raji Cell Line
Item number: BPS-82167
Firefly Luciferase CD19 Knockout Raji Cell Line is a Raji cell line constitutively expressing firefly (Photinus pyralis) luciferase under the control of a CMV promoter, where CD19 (Cluster of Differentiation 19, B-lymphocyte surface antigen B4, or CVID3) has been genetically removed using CRISPR/Cas9 genome editing....
| Keywords: | CD19, B-lymphocyte antigen CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte surface antigen... |
| Application: | CAR-T / NK co-culture killing assay control, in vitro/in vivo bioluminescence imaging |
| Species reactivity: | human |
8,192.00€
*
Firefly Luciferase CD19 Knockout NALM6 Cell Line
Item number: BPS-82168
Firefly Luciferase CD19 Knockout NALM6 Cell Line is a NALM6 cell line constitutively expressing Firefly (Photinus pyralis) luciferase under the control of a CMV promoter, in which CD19 (Cluster of Differentiation 19, B-lymphocyte surface antigen B4, or CVID3) has been genetically removed using CRISPR/Cas9 genome...
| Keywords: | CD19, B-lymphocyte antigen CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte surface antigen... |
| Application: | Negative control, in vitro/in vivo bioluminescence imaging, phenotype studies, CRISPR/Cas9 |
| Species reactivity: | human |
7,473.00€
*
PARG Knockout HeLa Cell Line
Item number: BPS-82171
PARG Knockout HeLa Cell Line is a HeLa cell line in which PARG (Poly ADP-ribose glycohydrolase) has been genetically removed using CRISPR/Cas9 genome editing with a lentivirus encoding CRISPR/Cas9 gene and sgRNA (single guide RNA) targeting human PARG.
| Keywords: | Poly(ADP-ribose) glycohydrolase, |
| Application: | Negative control, PARG knockout phenotype studies, CRISPR/Cas9-based genetic manipulation |
| Species reactivity: | human |
3,617.00€
*
TRbeta-GAL4 Luciferase Reporter HEK293 Cell Line (Thyroid...
Item number: BPS-82175
The TRbeta-GAL4 Luciferase Reporter HEK293 Cell Line is a HEK293 cell line expressing firefly luciferase under the control of the GAL4 upstream activation sequence (UAS) with constitutive expression of human thyroid receptor beta ligand binding domain (TRbeta LBD, amino acids 173-461) fused to the DNA binding domain...
| Keywords: | Luciferase, Luciferin 4-monooxygenase, |
| Application: | TRbeta agonist screening |
16,117.00€
*
CD36 Knockout THP-1 Cell Line
Item number: BPS-82190
CD36 Knockout THP-1 Cell Line is a THP-1 cell line where CD36 (Cluster of Differentiation 36) has been genetically removed from THP-1 cells using CRISPR/Cas9 genome editing via the use of a lentivirus encoding CRISPR/Cas9 gene and sgRNA (single guide RNA) targeting human CD36.
| Keywords: | FAT, GP3B, GPIV, CD36, PAS-4, PAS IV, GPIIIB, Glycoprotein IIIb, Fatty acid translocase, Platelet glycoprotein 4,... |
| Application: | Cellular mechanism studies, CD36 knockout disease studies, CRISPR/Cas9-based genetic manipulation |
| Species reactivity: | human |
8,731.00€
*
FcGR1a (CD64) Knockout THP-1 Cell Line
Item number: BPS-82191
FcGR1a (CD64) Knockout THP-1 Cell Line is a THP-1 cell line in which FcGR1a (Fc Gamma Receptor Ia or CD64) has been genetically removed from THP-1 cells using CRISPR/Cas9 genome editing with a lentivirus encoding CRISPR/Cas9 gene and sgRNA (single guide RNA) targeting human FcGR1a (CD64).
| Keywords: | CD64, FcRI, FCG1, FCGR1A, FcgammaRIa, Fc-gamma RI, Fc-gamma RIA, IgG Fc receptor I, High affinity immunoglobulin gamma Fc... |
| Application: | cGR1a (CD64) knockout phenotyp studies, CRISPR/Cas9-based genetic manipulations, negative control |
| Species reactivity: | human |
8,731.00€
*
Anti-CD19 CAR-T Cells (eGFP)
Item number: BPS-78789
Anti-CD19 CAR-T Cells (eGFP) were produced by high-titer lentiviral transduction of human primary CD4+ and CD8+ T cells with SIN Anti-CD19 CAR Lentivirus (CD19 ScFv-CD8-4-1BB-CD3zeta eGFP) (#78775). These ready-to-use CAR (Chimeric Antigen Receptor)-T cells express an anti-CD19 CAR consisting of the ScFv (Single...
| Keywords: | Anti-CD19, Anti-B-lymphocyte antigen CD19, Anti-Differentiation antigen CD19, Anti-T-cell surface antigen Leu-12,... |
| Application: | Positive control, modulator screening, co-culture cytotoxicity assay design/optimization |
| Species reactivity: | human |
2,427.00€
*
Dual Epitope Anti-BCMA CAR-T Cells
Item number: BPS-78790-1
The Dual Epitope Anti-BCMA CAR-T Cells are generated via high-titer lentiviral transduction of human primary CD4+ and CD8+ T cells with the SIN Anti-BCMA CAR Lentivirus (VHH1/VHH2 ScFv-CD8-4-1BB-CD3zeta) (#78783). These ready-to use CAR (chimeric antigen receptor)-T cells express an anti-BCMA CAR consisting of a...
| Keywords: | BCM, CD269, TNFRSF17, B-cell maturation protein, Tumor necrosis factor receptor superfamily member 17, |
| Application: | Positive control, modulator screening, co-culture cytotoxicity assay design/optimization |
| Species reactivity: | human |
From 2,313.00€
*